Candel Therapeutics Inc (CADL) Stock Analysis

Candel Therapeutics Inc (CADL) is a publicly traded company in the HEALTHCARE sector. It trades at $8.42, carries a market capitalization of $608.14M. This page summarizes the public market data, fundamentals, and frequently asked questions for CADL, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $8.42
• Market Cap: $608.14M
• EPS: $-1.01
• 52-Week High: $9.27
• 52-Week Low: $4.35

Market Sentiment

Candel Therapeutics Inc currently has a Bullish sentiment score of 0.15.

About Candel Therapeutics Inc

None

GNG Research Analysis

GNG Research scores Candel Therapeutics Inc (CADL) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for CADL.

Frequently Asked Questions

Does CADL pay dividends?

Candel Therapeutics Inc (CADL) does not currently pay a regular dividend.

What is CADL's market cap?

Candel Therapeutics Inc (CADL) has a market capitalization of $608.14M with a current stock price of $8.42.